Kinetics of the Lactate to Albumin Ratio in New Onset Sepsis: Prognostic Implications
Diagnostics · 08.09.2024 · 14 (17) · 1988
DOI: 10.3390/diagnostics14171988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 08.09.2024. Verfasst von Irene Karampela und 5 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Critical Care, Attikon General University Hospital, Medical School, National and Kapodistrian University of Athens, 1 Rimini St.…. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
The lactate to albumin ratio (LAR) has been associated with the severity and outcome of critical illness and sepsis. However, there are no studies on the kinetics of the LAR during the early phase of sepsis. Therefore, we aimed to investigate the LAR and its kinetics in critically ill patients with new onset sepsis regarding the severity and outcome of sepsis. We prospectively enrolled 102 patients with sepsis or septic shock within 48 h from diagnosis. LARs were recorded at inclusion in the study and one week later. Patients were followed for 28 days. LAR was significantly lower one week after enrollment compared to baseline in all patients (p < 0.001). LARs were significantly higher in patients with septic shock and in nonsurvivors compared to patients with sepsis and survivors, respectively, both at inclusion (p < 0.001, p < 0.001) and at one week later (p < 0.001, p < 0.001). LARs at baseline were positively associated with the severity of sepsis (APACHE II: r = 0.29, p = 0.003; SOFA: r = 0.33, p < 0.001) and inflammatory biomarkers, such as C-reactive protein (r = 0.29, p < 0.1), procalcitonin (r = 0.47, p < 0.001), interleukin 6 (r = 0.28, p = 0.005) interleukin 10 (r = 0.3, p = 0.002) and suPAR (r = 0.28, p = 0.004). In addition, a higher LAR, but not its kinetics, was an independent predictor of 28-day mortality (at inclusion: HR 2.27, 95% C.I. 1.01–5.09, p = 0.04; one week later: HR: 4.29, 95% C.I. 1.71–10.78, p = 0.002). In conclusion, the LAR may be a valuable prognostic indicator in critically ill patients with sepsis at admission and one week later.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Department of Critical Care, Attikon General University Hospital, Medical School, National and Kapodistrian University of Athens, 1 Rimini St., Haidari, 12462 Athens, Greece.
- Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias St., Goudi, 11527 Athens, Greece.
- Diabetes Center, First Department of Propaedeutic Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Department of Internal Medicine, Sismanogleio General Hospital, 1 Sismanogleiou St., 15126 Athens, Greece.
- First Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
ORCID-Profile: Irene Karampela, Dimitris Kounatidis, Natalia G Vallianou, Dimitrios Tsilingiris, Maria Dalamaga
Zitieren
APA
Karampela, I., Kounatidis, D., Vallianou, N. G., Panagopoulos, F., Tsilingiris, D., & Dalamaga, M. (2024). Kinetics of the Lactate to Albumin Ratio in New Onset Sepsis: Prognostic Implications. Diagnostics, 14(17), 1988. https://doi.org/10.3390/diagnostics14171988
Vancouver
Karampela I, Kounatidis D, Vallianou NG, Panagopoulos F, Tsilingiris D, Dalamaga M. Kinetics of the Lactate to Albumin Ratio in New Onset Sepsis: Prognostic Implications. Diagnostics. 2024;14(17):1988. doi:10.3390/diagnostics14171988
BibTeX
@article{Karampela2024,
author = {Karampela, Irene and Kounatidis, Dimitris and Vallianou, Natalia G and Panagopoulos, Fotis and Tsilingiris, Dimitrios and Dalamaga, Maria},
title = {Kinetics of the Lactate to Albumin Ratio in New Onset Sepsis: Prognostic Implications},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {17},
pages = {1988},
doi = {10.3390/diagnostics14171988}
}
EUVIMED